Chondroitin Sulfate
Also known as: Chondroitin, Chondroitin sulphate, CS
Randomized trials and meta-analyses provide inconsistent evidence. A 2024 meta-analysis of RCTs reported that chondroitin sulfate reduced pain and improved physical function versus placebo, whereas large trials (for example GAIT) found no significant benefit in the overall population; systematic reviews have judged the certainty of evidence to be low or unclear.
Last reviewed: 2026-10-14 · 4 indexed studies
Set your location for accurate regulatory status
Saved on this device — no sign-in needed.
Overview
Chondroitin sulfate is a glycosaminoglycan commonly sold as an oral supplement for osteoarthritis and joint health. Human trials and systematic reviews report mixed results: some meta-analyses and RCTs report modest reductions in pain and improvements in function, while large trials and reviews find little or uncertain benefit overall.
Mechanism & Function
Mechanism of Action
Proposed actions include provision of substrate for cartilage matrix and modulation of inflammatory processes in joints, but the clinical mechanism remains uncertain and is not established by the provided human trials.
Physiological Role
A constituent of cartilage extracellular matrix and joint connective tissue; suggested to influence cartilage homeostasis and joint pain pathways.
Primary Pathways
Performance / Health Relevance
Relevant mainly to symptomatic management of osteoarthritis (pain and function). Evidence does not support ergogenic or performance-enhancing effects in healthy athletes based on the provided abstracts.
Evidence Review
Practical Use & Dosage
- Minimum Effective Dose
- 1200 mg/day (dose studied in multiple RCTs)
- Optimal Range
- Approximately 1200 mg/day as used in trials; some formulations combine with glucosamine (e.g. 1500 mg glucosamine + 1200 mg chondroitin)
- Upper / Caution Level
- Not established
- Timing
- Oral, once daily as per trial regimens
- Best Format
- Oral tablet/capsule containing chondroitin sulfate
- Bioavailability
- Not addressed in the provided abstracts
- Absorption Considerations
- Not addressed in the provided abstracts
Safety & Interactions
Side Effects
- •Generally mild and similar to placebo in RCTs (gastrointestinal symptoms reported in some trials)
Contraindications
- None specifically reported in the provided abstracts
Drug Interactions
- •Not specified in the provided abstracts
Who Should Avoid
- •People with known hypersensitivity to product components
Monitoring
Adverse events in trials were generally mild and evenly distributed between groups; standard medical monitoring advised for people with comorbidities.
Frequently Asked Questions
Auto-generated from indexed evidence — dosage, safety, interactions, and more.
When is Chondroitin Sulfate typically used or indicated?
Chondroitin Sulfate is most commonly used for: Symptomatic management of osteoarthritis (joint pain and function), Part of combination products for joint support (e.g. with glucosamine). A constituent of cartilage extracellular matrix and joint connective tissue; suggested to influence cartilage homeostasis and joint pain pathways.
How does Chondroitin Sulfate work?
Proposed actions include provision of substrate for cartilage matrix and modulation of inflammatory processes in joints, but the clinical mechanism remains uncertain and is not established by the provided human trials.
What is the recommended dose of Chondroitin Sulfate?
The optimal range is Approximately 1200 mg/day as used in trials; some formulations combine with glucosamine (e.g. 1500 mg glucosamine + 1200 mg chondroitin). with a minimum effective dose of 1200 mg/day (dose studied in multiple RCTs). Best taken: Oral, once daily as per trial regimens. Upper / caution level: Not established.
What are the side effects of Chondroitin Sulfate?
Reported side effects include: Generally mild and similar to placebo in RCTs (gastrointestinal symptoms reported in some trials). Monitoring: Adverse events in trials were generally mild and evenly distributed between groups; standard medical monitoring advised for people with comorbidities.
Does Chondroitin Sulfate interact with medications?
Known or theoretical interactions: Not specified in the provided abstracts. Always check with a clinician before combining with prescription medication.
Who should avoid Chondroitin Sulfate?
Chondroitin Sulfate is generally not recommended for: People with known hypersensitivity to product components; and None specifically reported in the provided abstracts.
How strong is the evidence for Chondroitin Sulfate?
Evidence level: Limited (overall score 52/100), based on 4 indexed studies on SuppIndex.
Research & References (4)
Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study.
Randomized, double-blind trial comparing undenatured type II collagen (UC-II), glucosamine hydrochloride plus chondroitin sulfate (GC: 1500 mg glucosamine + 1200 mg chondroitin), and placebo for 180 days in knee osteoarthritis.
Evaluation of efficacy and safety of glucosamine sulfate, chondroitin sulfate, and their combination regimen in the management of knee osteoarthritis: a systematic review and meta-analysis.
Systematic review and meta-analysis (1994–2022) analysing RCTs of glucosamine sulfate, chondroitin sulfate, and their combination in knee osteoarthritis.
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
GAIT multicentre RCT comparing glucosamine 1500 mg, chondroitin sulfate 1200 mg, their combination, celecoxib, and placebo for 24 weeks in symptomatic knee osteoarthritis.
Is chondroitin sulfate effective for osteoarthritis?
Systematic review and meta-analysis summarising 50 randomized trials on chondroitin sulfate for osteoarthritis and using GRADE to assess certainty.
Related Ingredients
Other top-rated ingredients in General Health Ingredients.
Piperine
82/100A piperidine alkaloid (C₁₇H₁₉NO₃) that inhibits cytochrome P450 enzymes (CYP3A4, CYP1A2, CYP2E1), P-glycoprotein efflux transporters, and UDP-glucuronosyltransferases while enhancing intestinal permeability, digestive enzyme secretion, and splanchnic blood flow — collectively producing dramatic improvements in nutrient bioavailability.
CoQ10
78/100Endogenous lipid-soluble ubiquinone/ubiquinol that shuttles electrons in the mitochondrial respiratory chain and acts as a membrane antioxidant.
Beta-Glucan (Oat)
77/100Multiple randomized trials and meta-analyses report that ≥3 g/day oat beta-glucan lowers LDL and total cholesterol modestly. Acute feeding trials pooled in meta-analysis show dose- and molecular-weight–dependent reductions in postprandial glucose and insulin responses.
Research Overview
Limited EvidenceCite this ingredient
One-click citation export in APA, MLA, Chicago, BibTeX, or HTML. The URL below is stable and safe to link.
Stable URL
https://thesuppindex.com/ingredients/chondroitin-sulfate
SuppIndex. (2026). Chondroitin Sulfate: Evidence summary, dosage and clinical studies. Retrieved October 16, 2026, from https://thesuppindex.com/ingredients/chondroitin-sulfate
Based on 4 indexed studies · Evidence level: Limited.
Goal Ratings
Stack Compatibility
Often combined with glucosamine in trials; combination effects are mixed and may not be additive.